(Q34305874)

1 August 2017

title

Adenosine receptor-blocking xanthines as inhibitors of phosphodiesterase isozymes (English)

1 reference

1 August 2017

D. Ukena

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7680859

13 August 2024

C. Schudt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7680859

13 August 2024

G. W. Sybrecht

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7680859

13 August 2024

language of work or name

English

0 references

publication date

1 February 1993

1 reference

1 August 2017

24 February 1993

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7680859

full work available at URL

13 August 2024

https://api.elsevier.com/content/article/PII:000629529390168V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

https://api.elsevier.com/content/article/PII:000629529390168V?httpAccept=text/plain

13 August 2024

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

13 August 2024

published in

Biochemical Pharmacology

1 reference

1 August 2017

volume

45

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

847-851

1 reference

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors

1 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes

13 August 2024

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Subclasses of external adenosine receptors

13 August 2024

4

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Adenosine receptors: targets for future drugs

13 August 2024

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Analogues of 1,3-dipropyl-8-phenylxanthine: enhancement of selectivity at A1-adenosine receptors by aryl substituents

13 August 2024

8

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors

13 August 2024

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Analogs of caffeine: antagonists with selectivity for A2 adenosine receptors

13 August 2024

10

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors

13 August 2024

12

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Zardaverine as a selective inhibitor of phosphodiesterase isozymes

13 August 2024

13

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

A model for the regulation of the calmodulin-dependent enzymes erythrocyte Ca2+-transport ATPase and brain phosphodiesterase by activators and inhibitors

13 August 2024

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

An improved assay of cyclic 3',5'-nucleotide phosphodiesterases with QAE-Sephadex columns

13 August 2024

15

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Species differences in structure-activity relationships of adenosine agonists and xanthine antagonists at brain A1 adenosine receptors

13 August 2024

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Differentiation between bronchodilation and universal adenosine antagonism among xanthine derivatives

13 August 2024

17

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Effects of enprofylline on A1 and A2 adenosine receptors

13 August 2024

18

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes

13 August 2024

19

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

1,3-Dialkyl-8-(p-sulfophenyl)xanthines: potent water-soluble antagonists for A1- and A2-adenosine receptors

13 August 2024

21

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Inhibition of rat ventricular automaticity by adenosine

13 August 2024

22

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Binding of the A1-selective adenosine antagonist 8-cyclopentyl-1,3-dipropylxanthine to rat brain membranes

13 August 2024

23

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Adenosine receptor binding: structure-activity analysis generates extremely potent xanthine antagonists

13 August 2024

24

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors

13 August 2024

26

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

A [3H]amine congener of 1,3-dipropyl-8-phenylxanthine. A new radioligand for A2 adenosine receptors of human platelets

13 August 2024

28

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline

13 August 2024

30

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Phosphodiesterase inhibitors: new opportunities for the treatment of asthma

13 August 2024

31

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

8-phenyltheophylline as an inhibitor of cyclic AMP hydrolysis by cyclic nucleotide phosphodiesterase

13 August 2024

32

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Alkylxanthines: Inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity

13 August 2024

33

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: Evaluation of structure-activity relationships

13 August 2024

34

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Inhibition of separated forms of cyclic nucleotide phosphodiesterase from pig coronary arteries by 1,3-disubstituted and 1,3,8-trisubstituted xanthines

13 August 2024

35

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

A1- and A2-selective adenosine antagonists: in vivo characterization of cardiovascular effects

13 August 2024

36

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

Caffeine and theophylline analogues: correlation of behavioral effects with activity as adenosine receptor antagonists and as phosphodiesterase inhibitors

13 August 2024

37

1 reference

https://api.crossref.org/works/10.1016/0006-2952(93)90168-V

13 August 2024

Identifiers

1 reference

1 August 2017

1 reference